These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

375 related articles for article (PubMed ID: 37194014)

  • 1. Comprehensive analysis of m6A related gene mutation characteristics and prognosis in colorectal cancer.
    Jiang T; Xing L; Zhao L; Ye Z; Yu D; Lin S
    BMC Med Genomics; 2023 May; 16(1):105. PubMed ID: 37194014
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterizing m6A modification factors and their interactions in colorectal cancer: implications for tumor subtypes and clinical outcomes.
    Sun W; Su Y; Zhang Z
    Discov Oncol; 2024 Sep; 15(1):457. PubMed ID: 39292326
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Constructing and validating of m6a-related genes prognostic signature for stomach adenocarcinoma and immune infiltration: Potential biomarkers for predicting the overall survival.
    Yang J; Wu Z; Wu X; Chen S; Xia X; Zeng J
    Front Oncol; 2022; 12():1050288. PubMed ID: 36620557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of m6A methyltransferase-related genes predicts prognosis and immune infiltrates in head and neck squamous cell carcinoma.
    Zhang Y; Li L; Ye Z; Zhang L; Yao N; Gai L
    Ann Transl Med; 2021 Oct; 9(20):1554. PubMed ID: 34790760
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The potential role of RNA N6-methyladenosine in primary Sjögren's syndrome.
    Xiao Q; Wu X; Deng C; Zhao L; Peng L; Zhou J; Zhang W; Zhao Y; Fei Y
    Front Med (Lausanne); 2022; 9():959388. PubMed ID: 36465909
    [TBL] [Abstract][Full Text] [Related]  

  • 6. m6A-Related Genes Contribute to Poor Prognosis of Hepatocellular Carcinoma.
    Zou Y; Jiang G; Xie Y; Li H
    Comput Math Methods Med; 2022; 2022():2427987. PubMed ID: 36339682
    [TBL] [Abstract][Full Text] [Related]  

  • 7. m6A Regulators Is Differently Expressed and Correlated With Immune Response of Esophageal Cancer.
    Zhao H; Xu Y; Xie Y; Zhang L; Gao M; Li S; Wang F
    Front Cell Dev Biol; 2021; 9():650023. PubMed ID: 33748145
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pan-Cancer Prognostic, Immunity, Stemness, and Anticancer Drug Sensitivity Characterization of N6-Methyladenosine RNA Modification Regulators in Human Cancers.
    Li R; Yin YH; Ji XL; Liu X; Li JP; Qu YQ
    Front Mol Biosci; 2021; 8():644620. PubMed ID: 34150845
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Abnormal genetic and epigenetic patterns of m6A regulators associated with tumor microenvironment in colorectal cancer.
    Ren S; Xiao Y; Wang H; Zhao L; Li H; Wei L; Huang Y; Liu H
    Transl Cancer Res; 2023 Aug; 12(8):2033-2047. PubMed ID: 37701104
    [TBL] [Abstract][Full Text] [Related]  

  • 10. N6-methyladenosine RNA methylation regulator-related alternative splicing gene signature as prognostic predictor and in immune microenvironment characterization of patients with low-grade glioma.
    Maimaiti A; Tuersunniyazi A; Meng X; Pei Y; Ji W; Feng Z; Jiang L; Wang Z; Kasimu M; Wang Y; Shi X
    Front Genet; 2022; 13():872186. PubMed ID: 35937991
    [No Abstract]   [Full Text] [Related]  

  • 11. Gene Alterations of N6-Methyladenosine (m
    Zhang Q; Cai Y; Kurbatov V; Khan SA; Lu L; Zhang Y; Johnson CH
    Biomed Res Int; 2020; 2020():8826456. PubMed ID: 33415160
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Construction and validation of stemness-related lncRNA pair signature for predicting prognosis in colorectal cancer.
    Thandar M; Zhu Y; Zhang X; Chen Z; Zhao Y; Huang S; Chi P
    J Cancer Res Clin Oncol; 2023 Oct; 149(13):11815-11828. PubMed ID: 37410143
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of m6A RNA methylation regulators on endometrial cancer.
    Zhang Y; Yang Y
    J Clin Lab Anal; 2021 Sep; 35(9):e23942. PubMed ID: 34347888
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genomic and transcriptomic alterations in m6A regulatory genes are associated with tumorigenesis and poor prognosis in head and neck squamous cell carcinoma.
    Paramasivam A; George R; Priyadharsini JV
    Am J Cancer Res; 2021; 11(7):3688-3697. PubMed ID: 34354868
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exploring the role of m6A methylation regulators in glioblastoma multiforme and their impact on the tumor immune microenvironment.
    Deng X; Sun X; Hu Z; Wu Y; Zhou C; Sun J; Gao X; Huang Y
    FASEB J; 2023 Sep; 37(9):e23155. PubMed ID: 37606566
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Investigating the prognostic value of m6A methylation-related genes in renal cell carcinoma patients.
    Ge GC; Wang CH
    Eur Rev Med Pharmacol Sci; 2023 Dec; 27(24):11932-11946. PubMed ID: 38164857
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comprehensive characterization of tumor microenvironment and m6A RNA methylation regulators and its effects on PD-L1 and immune infiltrates in cervical cancer.
    Ji H; Zhang JA; Liu H; Li K; Wang ZW; Zhu X
    Front Immunol; 2022; 13():976107. PubMed ID: 36091006
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NME6 as a potential biomarker and therapeutic target involved in immune infiltration for lung adenocarcinoma.
    Luo L; Li Y; Zhang L; Yang L
    Technol Health Care; 2024; 32(4):2277-2291. PubMed ID: 38517815
    [TBL] [Abstract][Full Text] [Related]  

  • 19. m6A regulator-mediated RNA methylation modification patterns are involved in the regulation of the immune microenvironment in ischaemic cardiomyopathy.
    Zheng PF; Hong XQ; Liu ZY; Zheng ZF; Liu P; Chen LZ
    Sci Rep; 2023 Apr; 13(1):5904. PubMed ID: 37041267
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression patterns and prognostic value of m
    Liu X; Liu L; Dong Z; Li J; Yu Y; Chen X; Ren F; Cui G; Sun R
    Am J Transl Res; 2019; 11(7):3972-3991. PubMed ID: 31396313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.